Spinal Muscular Atrophy Medicine Market Will Record an Upsurge in Revenue during 2023-28

A new report has been published by Stratview Research, titled, “Spinal Muscular Atrophy Medicine Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2021–2026.” The experts authoring this report have made an effort at providing in-depth information on leading growth drivers, restrictions, challenges, current and upcoming trends, and opportunities to offer a comprehensive assessment of the Spinal Muscular Atrophy Medicine Market. Users can use the analysis included in this report to plan effective growth strategies and prepare for future challenges beforehand.

Market Insights

The spinal muscular atrophy medicine market is projected to grow from USD 980.6 million in 2020 to USD 2,085.4 million by 2026 at a CAGR of 13.4% during the forecast period.

What is Spinal Muscular Atrophy (SMA)?

Spinal Muscular Atrophy (SMA) is a very rare genetic disorder that affects the part of the central nervous system that controls voluntary muscle movements. SMA is an autosomal recessive neurodegenerative genetic disorder that is characterized by atrophy and the weakening of muscles. It is one of the most common debilitating genetic disorders and a primary genetic cause of death among infants. It mainly affects approximately one in 10,000 live births across the globe.

Market Dynamics

Rising incidence and awareness of spinal muscular atrophy has surged significantly which is likely to spur the need for efficient therapeutic options, resulting in better patient outcomes.

• Growing awareness regarding SMA worldwide and a rising number of initiatives to enhance the treatment options for such rare diseases are some of the prime factors bolstering SMA medicine demand.
• Also, favorable initiatives undertaken by the government, public, and non-profit organizations for spreading awareness regarding SMA are further augmenting the market growth.
• However, the high cost associated with SMA treatment and medicines is likely to hinder the industry's growth.

Market segmentation

Market segmentation has been done correctly to help the users define and better understand their target audiences and ideal customers. Market segmentation in this report allows you to identify the right market for your products and then target your marketing more effectively.

By treatment, the spinal muscular atrophy medicine market has been segmented into gene therapy and drug. Under these, the drug segment garnered the highest market share in 2020 and is likely to register a substantial CAGR during the review period. The SMA Foundation financed more than USD 60 Mn in drug development programs and essential drug discovery assets in 2015 that aimed at developing an effective SMA therapy. Also, Spinraza is the only medicinal drug approved for the treatment of SMA to date, further propelling segment growth.

By region, North America accounted for the highest market share in 2020 and is estimated to grow at a steady CAGR during the assessment period.

• This is mainly ascribed to growing healthcare expenditure, high disposable income, improving standards of living with large population growth, and the rise in the adoption of Spinraza, which boosts regional growth.
• Also, there is an increase in the number of initiatives undertaken by private companies and NGOs to spread awareness and support R&D activities for the treatment of SMA.

Competitive landscape

Relying on data to make business decisions and to have a competitive advantage, is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the Spinal Muscular Atrophy Medicine Market along with a list of Key players.

Here are a few–

• Biogen (The U.S),
• Ionis Pharmaceuticals, Inc. (The U.S),
• F. Hoffmann - La Roche Ltd (Switzerland),
• Avexis, Inc. (The U.S),
• Novartis AG (Switzerland),
• Cytokinetics, Inc. (The U.S),
• Pfizer Inc. (The U.S),
• Boehringer Ingelheim International GmbH (Germany),
• Regeneron Pharmaceuticals, Inc (The U.S), and
• Abbott (The U.S).

Report Features -

This market report includes the following features –

• Market structure: Overview, industry life cycle analysis, supply chain analysis.
• Market environment analysis: Growth drivers and constraints.
• Market trend and forecast analysis.
• Competitive landscape and dynamics: Market share, Product portfolio, New Product Launches, M&As etc.
• Attractive market segments and associated growth opportunities.
• Emerging trends.

Custom Research:

Stratview research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com

About Stratview Research –

Stratview Research is a leading market research firm that offers a wide range of services like syndicated market reports, consulting, sourcing intelligence, customer research, etc. Stratview Research’s offerings include comprehensive market intelligence in the form of research reports, and consulting services. Our team which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 500 companies.

Article source: https://article-realm.com/article/Business/Marketing/47556-Spinal-Muscular-Atrophy-Medicine-Market-Will-Record-an-Upsurge-in-Revenue-during-2023-28.html